|
|
| Antalgiques > Etude de marché sectorielle |
|
|
|
|
€ 3 091,00 |
Editeur
: |
Global Industry Analysts, Inc. |
Langue
: |
Anglais |
Date de publication : |
Janvier 2006 |
Taille du document : |
459 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
Documents Publics |
1,200,000
documents |
Téléchargement illimités |
|
|
|
Etudes Privées |
50,000 rapports et études |
Paiement à la piéce |
|
|
|
|
| |
|
1.Télécharger nos rapports publics
Accés complet à plus de 1,2 Million de documents publics : études de marché, statistiques sectorielles, fiches pays, monographie d'entreprises, veille concurentielle, rapports annuels...
|
| Nos documents publics sur le même théme (5) |
|
|
|
| 86 pages | Août 2005 | Anglais
|
|
|
| Main
focus: |
pharmaceuticals,pharmaceutical,pharmacovigilance
|
| Research
focus: |
industry structure,market size and estimates, |
| Geographic
focus: |
usa,united kingdom,india,germany,thailand,nigeria,... |
| |
|
|
|
|
| 96 pages | Anglais
|
|
|
| Main
focus: |
pharmaceuticals,pharmaceutical,...,banks
|
| Research
focus: |
market size and estimates,market definition, |
| Geographic
focus: |
usa,china,france,canada,bermuda,israel,russia,... |
| |
|
|
|
|
| 64 pages | Mars 2005 | Anglais
|
|
|
| Main
focus: |
pharmaceuticals,atherosclerosis,hypertension
|
| Research
focus: |
market size and estimates,market outlook, |
| Geographic
focus: |
usa,france,canada |
| |
|
|
|
|
| 64 pages | Novembre 2005 | Anglais
|
|
|
| Main
focus: |
pharmaceuticals,dyslipidemia,pharmaceutical,...,...
|
| Research
focus: |
market size and estimates,market outlook, |
| Geographic
focus: |
usa,france,canada,poland |
| |
|
|
|
|
| 70 pages | Septembre 2006 | Anglais
|
|
|
| Main
focus: |
pharmaceuticals,pharmaceutical,...
|
| Research
focus: |
market size and estimates,industry structure, |
| Geographic
focus: |
india,usa,china,france,united kingdom,malaysia,... |
| |
|
|
|
|
| Autres recherches sur le même thème |
|
|
|
| |
| |
|
| |
|
2.
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
US State Market Index: Anesthetics, in bulk form
12 pages | Juillet 2006 |
The metrics in this report cover three year trends in Anesthetics, in bulk form [Manufacturing sector], broken out on a state-by-state basis.
Analysis is based on data applied from 11 industry firm |
475,00 €
|
| |
| |
OTC Analgesics in France
10 pages | Juin 2005 |
Euromonitor International’s ‘OTC Analgesics in France' Major Market Profile report offers an introduction to the market.
It is c.
10 pages long and provides a top line overview of sales trends |
198,00 €
|
| |
| |
US Analgesics 2004
14 pages | Juillet 2004 |
Snapdata's US Analgesics 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US analgesic market, and covers non |
240,00 €
|
| |
| |
Commercial Insight: Neuropathic Pain - A Plethora of Patient Segmentation and Product Differentiation Opportunities
131 pages | Juillet 2006 |
IntroductionNeurontin (gabapentin) has finally been knocked off the top spot as a result of fierce generic incursion.
However, Pfizer's follow-on Lyrica (pregabalin), Lilly's Cymbalta (duloxetine) |
12 160,00 €
|
| |
| |
US State Market Index: Analgesics
12 pages | Juillet 2006 |
The metrics in this report cover three year trends in Analgesics [Manufacturing sector], broken out on a state-by-state basis.
Analysis is based on data applied from 7 industry firms.
Industry m |
475,00 €
|
| |
| |
The Pain Market Outlook to 2011
206 pages | Juin 2006 |
The patient populations for neuropathic and nociceptive pain are large, and are driven by separate disease trends that necessitate pain relief; across the seven major markets in 2005 it was estimated |
2 300,00 €
|
| |
| |
Anesthesia Competitors
1 pages | Janvier 2006 |
This Database Table is a one-page table of hard-to-find numerical information.
The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif |
80,00 €
|
| |
| |
Pain Management
459 pages | Janvier 2006 |
This report analyzes the worldwide markets for Pain Management in Millions of US$.
The specific product segments analyzed are Pain Management Pharmaceuticals, Pain Management Devices, and Pain Mana |
3 091,00 €
|
| |
| |
Pipeline Insight: Neuropathic Pain - Pipeline Drugs Fail to Nail Neuropathic Pain
183 pages | Juillet 2005 |
IntroductionThe neuropathic pain market has traditionally been a poorly defined area, with widely varying drug classes prescribed.
With many drugs now in clinical trials for key neuropathic pain su |
9 120,00 €
|
| |
| |
Pain Management
202 pages | Octobre 2006 |
Pain Management |
55,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
|
|
This report analyzes the worldwide markets for Pain Management in Millions of US$. The specific product segments analyzed are Pain Management Pharmaceuticals, Pain Management Devices, and Pain Management Services. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World. Annual forecasts are provided for each region for the period of 2001 through 2010. A ten-year historic analysis is also provided for these markets with annual market analytics. The report profiles 104 companies including many key and niche players worldwide such as AstraZeneca PLC, Aventis, Roxane Laboratories, Inc., Elan Corporation PLC, Eli Lilly and Company, Glaxo Smithkline Plc, Johnson & Johnson, Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Organon International, Inc., Pfizer, Inc., Roche, and Wyeth.
|
|
|
PPLSEN
|
|
|
|
|
